Discover REAC, a non-invasive neuromodulation technology that interacts with the body’s own bioelectric fields to combat neurodegenerative diseases like Alzheimer’s.
Neurodegenerative diseases, such as Alzheimer’s, present one of the most significant challenges in modern medicine. A groundbreaking, non-invasive therapeutic approach, known as REAC® (Radio Electric Asymmetric Conveyer) technology, offers a new paradigm in neuromodulation and biomodulation.
Mechanism of Action
Unlike conventional neurostimulation techniques (e.g., TMS, tDCS) that deliver external energy to stimulate or inhibit neural tissue, REAC® technology operates on a fundamentally different principle. It interacts with the body’s endogenous bioelectric fields, which are essential for cellular function and communication.
The core of the technology is the Asymmetric Conveyer probe. This device creates a unique physical link with the patient’s body, concentrating the microcurrents naturally generated by the body’s own tissues. This process helps to “reorganize” and optimize cellular polarity and the flow of ions, essentially re-tuning the body’s bioelectric communication system. The goal is to counteract the dysfunctional adaptive responses that underlie many chronic and neurodegenerative conditions, promoting a return to physiological balance.
Therapeutic Protocols and Evidence
The technology employs specific protocols, including Neuro Postural Optimization (NPO) and Neuro Psycho-Physical Optimization (NPPO), tailored to address different aspects of neurological and psychiatric dysfunction.
Scientific evidence, supported by both in-vitro and clinical studies, has demonstrated REAC’s ability to:
Conclusion
REAC® Technology represents a safe, painless, and side-effect-free advancement in medicine. By optimizing the body’s innate self-regulation mechanisms at a bioelectric level, it provides a promising new therapeutic avenue for managing complex neurodegenerative and psychiatric disorders.
Read the full article here.
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V